Recently, China’s National Healthcare Security Administration announced the upcoming release of Version 3.0 of the Diagnosis-Related Groups/Big Data Diagnosis-Intervention Packet (DRG/DIP 3.0) payment system, marking a new phase in the country’s healthcare reimbursement reform. This model standardizes diseases and treatment processes, assigning fixed reimbursement rates per diagnosis category. Version 1.0 established basic disease groupings and framework; Version 2.0 refined grouping logic and regional adaptability; and Version 3.0 now emphasizes precision management, dynamic adjustment mechanisms, and integration with clinical pathways.Key features of DRG/DIP 3.0 include: leveraging AI and big data to enhance the scientific accuracy and real-time responsiveness of disease classification; strengthening oversight on the appropriate use of high-cost consumables and innovative drugs/devices; shifting hospital incentives from ‘more procedures, more revenue’ to ‘better quality, greater efficiency, and cost control’; and establishing unified national data standards and feedback systems to foster synergy among health insurance, providers, and pharmaceutical sectors.The policy is expected to curb unnecessary medical spending, improve the efficiency of health insurance fund utilization, and encourage hospitals to streamline care delivery and enhance service quality. Experts note that the implementation of Version 3.0 will provide strong support for deepening healthcare reform and building a high-quality medical service system.
近日，国家医保局宣布即将发布‘医保按病种付费3.0版’（DRG/DIP 3.0），标志着我国医保支付方式改革进入新阶段。按病种付费是一种将疾病诊断、治疗过程标准化后，对每类病种设定固定支付标准的医保结算模式。1.0版主要完成病种分组和基础框架搭建，2.0版优化了分组逻辑与区域适配性，而3.0版则聚焦于精细化管理、动态调整机制和临床路径融合。3.0版的核心亮点包括：一是引入人工智能与大数据技术，提升病种分组的科学性和实时性；二是强化对高值耗材、创新药械的合理使用监管；三是推动医疗机构从‘多做项目多收入’转向‘提质增效控成本’；四是建立全国统一的数据标准和反馈机制，促进医保、医疗、医药协同发展。该政策有望进一步控制不合理医疗费用增长，提升医保基金使用效率，同时激励医院优化诊疗流程、提高服务质量。专家指出，3.0版的落地将为深化医改、构建高质量医疗服务体系提供有力支撑。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/6910.html